CD38 and B-cell chronic lymphocytic leukemia: CD38 is accepted as an indicator of activated CLL cells; CD38-expressing leukemic cells are characterized by enhanced response to B-cell receptor (BCR) signaling and increased cell migration ability (reviewed [24]).